Alucent Biomedical, Inc. — Form D

Alucent Biomedical, Inc. of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-27. The offering totals $400K, of which $400K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Michael ElliotDirectorAustin, TX
Ryan HansenDirectorSioux Falls, SD
David KapaskaDirectorSioux Falls, SD
Julie NortonDirectorSioux Falls, SD
Fred SluneckaDirectorSioux Falls, SD
Ryan HansenExecutive OfficerSioux Falls, SD
Daniel PelakDirectorAliso Viejo, CA
Julie LauttDirectorSalt Lake City, UT
James CorbettDirectorSalt Lake City, UT
Bruce KrattenmakerExecutive OfficerSalt Lake City, UT
Kevin WarnerExecutive OfficerSalt Lake City, UT
Colin JacksonExecutive OfficerSalt Lake City, UT
Myles GreenbergDirectorSalt Lake City, UT
Myles GreenbergExecutive OfficerSalt Lake City, UT
David FlicekDirectorSalt Lake City, UT
Katalin KauserExecutive OfficerSalt Lake City, UT
Nick PappasDirectorSalt Lake City, UT
James IsaacsonExecutive OfficerSalt Lake City, UT
Henry HauserExecutive OfficerSalt Lake City, UT
Dan D PelakDirectorSalt Lake City, UT
David N FlicekDirectorSalt Lake City, UT
Myles D GreenbergDirectorSalt Lake City, UT
Myles D GreenbergExecutive OfficerSalt Lake City, UT
James D CorbettDirectorSalt Lake City, UT
Scott N MayfieldExecutive OfficerSalt Lake City, UT

Other filings by this issuer (2)

FiledFormOfferingSold
2023-04-20D$11.2M$11.2M
2020-10-15D$35.0M$35.0M

More